Patents by Inventor Mustapha Haddach

Mustapha Haddach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11912706
    Abstract: The present invention relates to novel solid crystalline form of N-methyl-2-(4-methyl-1,4-diazepan-1-yl)benzo [4,5]imidazo[1,2-a][1,8]naphthyridine-6-carbaxomide, processes for the preparation thereof, compositions thereof and method of use thereof.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: February 27, 2024
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Patent number: 11866438
    Abstract: Generally, the present invention provides novel quinolone and 5H-1,5,7,11b-tetraaza-benzo[c]fluoren-6-one compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: March 17, 2021
    Date of Patent: January 9, 2024
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Publication number: 20230192694
    Abstract: The present invention relates to novel solid crystalline form of N-methyl-2-(4-methyl-1,4-diazepan-1-yl)benzo [4,5]imidazo[1,2-a][1,8]naphthyridine-6-carbaxomide, processes for the preparation thereof, compositions thereof and method of use thereof.
    Type: Application
    Filed: March 28, 2018
    Publication date: June 22, 2023
    Inventor: Mustapha HADDACH
  • Patent number: 11623928
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: July 9, 2020
    Date of Patent: April 11, 2023
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Patent number: 11618752
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: January 10, 2020
    Date of Patent: April 4, 2023
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Publication number: 20210317120
    Abstract: Generally, the present invention provides novel quinolone and 5H-1,5,7,11b-tetraaza-benzo[c]fluoren-6-one compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Application
    Filed: March 17, 2021
    Publication date: October 14, 2021
    Inventor: Mustapha HADDACH
  • Patent number: 10975076
    Abstract: Generally, the present invention provides novel quinolone and 5H-1,5,7,11b-tetraaza-benzo[c]fluoren-6-one compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: March 2, 2016
    Date of Patent: April 13, 2021
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Publication number: 20210094952
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Application
    Filed: July 9, 2020
    Publication date: April 1, 2021
    Inventor: Mustapha HADDACH
  • Publication number: 20200361937
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Application
    Filed: January 10, 2020
    Publication date: November 19, 2020
    Inventor: Mustapha HADDACH
  • Patent number: 10745403
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: June 3, 2019
    Date of Patent: August 18, 2020
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Patent number: 10590134
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: March 17, 2020
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Publication number: 20190389860
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Application
    Filed: June 3, 2019
    Publication date: December 26, 2019
    Inventor: Mustapha HADDACH
  • Patent number: 10442801
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: October 15, 2019
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Publication number: 20190233422
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Application
    Filed: March 2, 2016
    Publication date: August 1, 2019
    Inventor: Mustapha Haddach
  • Publication number: 20180291020
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Application
    Filed: January 8, 2018
    Publication date: October 11, 2018
    Inventor: Mustapha Haddach
  • Patent number: 9951066
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: April 11, 2017
    Date of Patent: April 24, 2018
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Publication number: 20180079750
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Application
    Filed: July 27, 2017
    Publication date: March 22, 2018
    Inventor: MUSTAPHA HADDACH
  • Publication number: 20170334905
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Application
    Filed: April 11, 2017
    Publication date: November 23, 2017
    Inventor: Mustapha Haddach
  • Patent number: 9758518
    Abstract: Generally, the present invention provides novel quinoline compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: September 12, 2017
    Assignee: PIMERA, INC.
    Inventor: Mustapha Haddach
  • Patent number: 9512123
    Abstract: Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: May 9, 2015
    Date of Patent: December 6, 2016
    Assignee: Pimera, Inc.
    Inventor: Mustapha Haddach